This cohort study analyzes the risk of second cancers in a cohort of 515 patients with Erdheim-Chester disease followed up at 2 histiocytosis centers in France and Italy.
No takes yet. Share an insight, caveat, or question.
Pegoraro et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: